Critical evaluation of a microrna-based risk classifier predicting cancer-specific survival in renal cell carcinoma with tumor thrombus of the inferior vena cava

HIGHLIGHTS

• who: Mischa J. Kotlyar and colleagues from the Department of Urology and Pediatric Urology, University Hospital Wu00fcrzburg, Wu00fcrzburg, Germany have published the research work: Critical Evaluation of a microRNA-Based Risk Classifier Predicting Cancer-Specific Survival in Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava, in the Journal: (JOURNAL) of 12/03/2023
• what: Although RCC extending into the inferior vena cava represents a high-risk setting, there is still substantial clinical heterogeneity within this patient subgroup.
• future: Research is needed to elucidate the potential impact of these miRs on . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.